US 11191757
Combination of pimavanserin and cytochrome P450 modulators
granted A61KA61K31/4468A61K31/496
Quick answer
US patent 11191757 (Combination of pimavanserin and cytochrome P450 modulators) held by ACADIA Pharmaceuticals Inc. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/4468, A61K31/496, A61K31/7048, A61K45/06